Pricing

Fennec Pharmaceuticals Inc (FENC)

followers ยท
Sector: HEALTH CARE
Industry: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO: Rostislav C. Raykov
Employees: 10
Web site: fennecpharma.com
PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
(919) 636-4530
    Formally known as:
  • Adherex Technologies Inc
  • Adherex Technologies Inc
  • Adherex Technologies, Inc. Ordinary
  • FENNEC PHARMACEUTICALS, INC
Stock Split History
Date Ratio
2005-08-02 1:5
2011-08-30 1:18
2014-09-05 1:3
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Fennec Pharmaceuticals Inc. develops product candidates for use in the treatment of cancer in the U.S. Its lead product PEDMARK is a formulation of Sodium Thiosulfate that has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children.
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% Change in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available